Trademark Overview
On Friday, May 8, 2026, a trademark application was filed for FITSTAR with the United States Patent and Trademark Office. The USPTO has given the FITSTAR trademark a serial number of 99812468. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Friday, May 8, 2026. This trademark is owned by Amplified Software LLC. The FITSTAR trademark is filed in the Computer & Software Products & Electrical & Scientific Products and Computer & Software Services & Scientific Services categories with the following description:
Software as a service (SAAS) services featuring software for generating personalized therapeutic treatment protocols such as peptides, hormones, and enzymes based on individual health data, goals, and ongoing outcome monitoring; Software as a service (SAAS) services featuring software for health monitoring, recommending and tracking personalized medication and therapeutic treatment protocols, managing side effects, and facilitating communications between patients and licensed healthcare providers; Software as a service (SAAS) services featuring software using artificial intelligence (AI) for health monitoring, recommending and tracking personalized medication and therapeutic treatment protocols, managing side effects, and facilitating communications between patients and licensed healthcare providers
Downloadable computer application software for mobile phones, namely, software for health monitoring, recommending and tracking personalized medication and therapeutic treatment protocols, managing side effects, and facilitating communications between patients and licensed healthcare providers; Downloadable computer application software for mobile phones, namely, software for generating personalized therapeutic personalized peptide treatment protocols, managing side effects, and facilitating communications between patients and licensed healthcare providers; Downloadable mobile applications using artificial intelligence (AI) for health monitoring, recommending and tracking personalized medication and therapeutic treatment protocols, managing side effects, and facilitating communications between patients and licensed healthcare providers